Human Milk Oligosaccharides (HMO) Market

DSM (Netherlands), BASF (Germany) and Dupont (US) are the Key Players in the HMO Market

The global Human milk oligosaccharides market is estimated to be valued at USD 199 million in 2022. It is projected to reach USD 556 million by 2027, recording a CAGR of 22.7% during the forecast period. Human milk oligosaccharides (HMOs) are among the major components of human milk, which is packed with essential nutrients to support human health. Some of the major types of HMOs are 2’FL, 3’FL, 3’SL, and 6’SL. On account of their numerous health benefits and a wide array of applications, 2’FL-based HMOs have become popular over the past few years. The introduction of HMO-based consumable products and the commercialization of the use of HMOs for industrial production are some of the major driving factors responsible for the overall growth of the human milk oligosaccharides market.

Key players in this market include DSM (Netherlands), BASF (Germany), CHR Hansen Holding A/S (Denmark), Dupont (US), and Nestle (Switzerland)

To know about the assumptions considered for the study download the pdf brochure

DSM is a global science-based company operating in the health, nutrition, and materials businesses. The company operates through four business segments-nutrition, materials, innovation center, and corporate activities. Its nutrition segment includes DSM Nutritional Products and DSM Food Specialties. The company offers specialty food ingredients under its DSM Food Specialties business. DSM offers a range of human milk oligosaccharides, such as 2FL, 3FL, LNnT, 3 SL, and 6 SL, under its human nutrition segment. It also offers feed additives through its animal nutrition & health division, which falls under the DSM Nutrition Products business. The company operates through more than 110 commercial production facilities in more than 40 countries, including the Netherlands, China, India, and Japan.The company has expanded its global presence by acquiring new facilities. It continuously upgrades its portfolio by launching new products. In April 2020, DSM completed the acquisition of Glycom (Denmark) to expand its product line of HMO to deliver novel ingredients for next-generation Early Life Nutrition solutions.

BASF SE is a leading chemical company listed on the stock exchanges in Frankfurt (Germany), London (UK), and Zurich (Switzerland). The company has 11 divisions grouped into six segments, namely chemicals, materials, industrial solutions, surface technologies, nutrition & care, and agricultural solutions. For financial reporting, it has organized its regional divisions into four: Europe, North America, Asia Pacific, and South America/Africa/Middle East. The nutrition & care segment of the company offers a comprehensive range of products across human nutrition, animal nutrition, pharma solutions, and aroma ingredients. BASF is one of the strongest suppliers of human milk oligosaccharides (human milk oligosaccharides) for the infant nutrition business supplying to all major companies in the pharma, nutraceutical, and dietary supplement industries. The company has focused on introducing innovative product portfolio to solidify its market share in the human milk oligosaccharides market. In May 2019, BASF SE and Glycosyn (US) signed a partnership agreement for the development and commercialization of human milk oligosaccharides for broad use in dietary supplements, functional nutrition, and medical food.

DuPont is one of the leading global companies that offer science-based products and services, particularly chemicals. The company operates through five major business segments, namely electronics & imaging, nutrition & biosciences, transportation & industrial, safety & construction, and non-core. It offers functional food ingredients under its nutrition & biosciences segment. The three major product lines of the company under the nutrition & biosciences segment include food & beverage, health & biosciences, and pharma solutions. Functional food ingredients offered by the company include prebiotics, probiotics, protein, fibers, and tailored ingredients. The company has laboratories in nearly 90 countries across North America, Asia Pacific, South America, Europe, Africa, and the Middle East. In February 2020, DuPont (US) added a new product named as CARE4U-3FL under its human milk oligosaccharides portfolio. CARE4U-3FL is used for formulating infant formulas and toddler foods and is used as a dietary ingredient in supplements across the US and Europe.

Related Reports:

Human Milk Oligosaccharides Market by Type (2’ Fl, 3’ Fl, 3’ Sl, 6’ Sl), Application (Infant Formula, Functional Food & Beverages, Food Supplement), Concentration (Acidic, Neutral) & Region (North America, Europe, APAC, South America, RoW) - Global Forecast to 2027

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Human Milk Oligosaccharides (HMO) Market Size,  Share & Growth Report
Report Code
FB 8086
RI Published ON
Choose License Type

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2024 MarketsandMarkets Research Private Ltd. All rights reserved Protection Status